New hope for kids with rare kidney disease: drug may cut dialysis time
NCT ID NCT02205541
First seen May 06, 2026 · Last updated Jun 18, 2026 · Updated 10 times
Summary
This study tested whether the drug eculizumab can help children with a serious kidney disease called STEC-HUS, which is caused by a type of E. coli infection. About 100 children aged 1 month to 18 years received either eculizumab or a placebo. The main goal was to see if the drug reduces the number of days they need dialysis. The study aims to provide clear evidence on whether this treatment is safe and effective.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMOLYTIC UREMIC SYNDROME OF CHILDHOOD are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Anne de Bretagne University Hospital
Rennes, 35056, France
-
Clocheville Hospital
Tours, 37044, France
-
Jeanne de Flandre Hospital
Lille, 59037, France
-
La Timone Hospital
Marseille, France
-
Morvan Hospital
Brest, 29609, France
-
Mother and Child Hospital
Limoges, 87000, France
-
Mother and Child Hospital
Nantes, 44000, France
-
Necker Hospital
Paris, 75743, France
-
Pellegrin Hospital
Bordeaux, 33000, France
-
Purpan Children Hospital
Toulouse, 31059, France
-
Robert Debré Hospital
Paris, 75019, France
-
Trousseau Hospital
Paris, 75571, France
-
University Hospital
Amiens, 80054, France
-
University Hospital
Angers, 49100, France
-
University Hospital
Besançon, 25030, France
-
University Hospital
Grenoble, 60107, France
-
University Hospital
Montpellier, 34295, France
-
Women, Mother and Child Hospital
Lyon, 69500, France
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.